Mehjabeen Sadiq, MD
Endocrinology, Diabetes & Metabolism · Morgantown, WVNPI 1205482890
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Novo Nordisk at 38.8% of the total. 2025 is the largest year on record at $372, more than ten times the $13 reported in 2022. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in WV, where the typical reported total is $1,166.
Across 32 payments — averaging $21.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$266
- Medtronic$155
- Ascendis Pharma Endocrinology Inc$49
- Antares Pharma, Inc.$47
- Insulet Corporation$46
- Xeris Pharmaceuticals, Inc.$43
- plus $79 from 5 others
What the payments were for
- Food & beverage$684100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 17 | $266 |
| Medtronic | 2 | $155 |
| Ascendis Pharma Endocrinology Inc | 2 | $49 |
| Antares Pharma, Inc. | 2 | $47 |
| Insulet Corporation | 2 | $46 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| Corcept Therapeutics | 1 | $23 |
| Tandem Diabetes Care, Inc. | 1 | $15 |
| Radius Health, Inc. | 1 | $14 |
| Sequel Med Tech, LLC | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$130
How this compares
$684 in reported general payments places this provider in the 30th percentile of 57 endocrinology, diabetes & metabolism providers in West Virginia.
See all endocrinology, diabetes & metabolism providers in West Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 35 | $39,181 |
| MounjaroTirzepatide | 27 | $28,636 |
| TrulicityDulaglutide | 21 | $20,153 |
| Icosapent Ethyl | 12 | $1,796 |
| Hydrocortisone | 11 | $637 |
| Levothyroxine Sodium | 44 | $571 |
| Ultra-Fine Nano Pen NeedlePen Needle, Diabetic | 12 | $294 |
| Metformin Hcl ErMetformin Hcl | 16 | $103 |
| Methimazole | 11 | $60 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $266 | $39,18135 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 57 endocrinology, diabetes & metabolism providers in West Virginia.
Other endocrinology, diabetes & metabolism in Morgantown
- Jessica PeriniMorgantown$10K
- Jennifer TurnerMorgantown$6K
- Adnan HaiderMorgantown$3K
- Jennifer GiordanoMorgantown$2K
- Nadia BarghouthiMorgantown$1K
- Apoorva IyerMorgantown$1K
- Jeffrey Zen-Ji RicoMorgantown$1K
- Tariq LatifMorgantown$844
- Sarah FatimaMorgantown$292
- Ann-Marie BusickMorgantown$227
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.